Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × Panitumumab × Clear all

NCT05121038 2024-12-17

CENDIFOX

Phase 1/2 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms

NCT01175733 2017-03-20

Vectibix

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms